2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$19.16+$0.25 (+1.31%)
Price as of Jul 14, 2026 6:30 AM EDT- $994.0MMarket Cap
- 285.92%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$19.16+$0.25 (+1.31%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
ARMISTICE CAPITAL, LLC | 35.10% | 4.0M | 0 (0.00%) | Dec 31, 2022 |
FMR LLC | 25.50% | 2.9M | +2.7M (+92.35%) | Mar 31, 2026 |
T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 19.15% | 2.2M | +2.2M (+100.00%) | Mar 31, 2026 |
CALIGAN PARTNERS LP | 14.48% | 1.6M | +753,490 (+46.08%) | Mar 31, 2026 |
BVF INC/IL | 14.46% | 1.6M | +277,588 (+17.00%) | Mar 31, 2026 |
STONEPINE CAPITAL MANAGEMENT, LLC | 13.37% | 1.5M | +660,095 (+43.71%) | Dec 31, 2021 |
AVORO CAPITAL ADVISORS LLC | 12.48% | 1.4M | +1.4M (+100.00%) | Mar 31, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 23.98% | 2.7M | 0 (0.00%) | Mar 31, 2026 |
FIDELITY CONCORD STREET TRUST | 7.13% | 805,083 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY CAPITAL TRUST | 6.95% | 785,400 | +785,400 (+100.00%) | Apr 30, 2026 |
FIDELITY SECURITIES FUND | 4.93% | 556,500 | +556,500 (+100.00%) | Apr 30, 2026 |
FIDELITY SALEM STREET TRUST | 4.01% | 452,820 | 0 (0.00%) | Apr 30, 2026 |
FIDELITY ADVISOR SERIES VII | 3.17% | 358,300 | +138,000 (+38.52%) | Apr 30, 2026 |
COLLEGE RETIREMENT EQUITIES FUND | 2.14% | 242,233 | 0 (0.00%) | Mar 31, 2026 |
Current Ownership Distribution
- Institutions245.7M (70.31%)
- Mutual Funds53.3M (15.26%)
- Insiders50.4M (14.43%)
- Other0 (0.00%)
Insider Transactions
- 14.43% (50.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 3Number of InsiderSelling (last 12 months)
- $3.4MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
Lind Kevin Robert | Award | Jun 30, 2026 | $16,619.20 | 1,105 | $15.04 | 1,105 |
Philip Ron M | Award | Jun 30, 2026 | $1,037.76 | 69 | $15.04 | 69 |
Doyle Mittie Chief Medical Officer | Exempt | Jun 30, 2026 | $0.00 | 2,875 | $0.00 | 125,750 |
Jain Rita | Award | Jun 30, 2026 | $16,243.20 | 1,080 | $15.04 | 1,080 |
Doyle Mittie Chief Medical Officer | Exempt | Jun 30, 2026 | $0.00 | 1,779 | $0.00 | 115,092 |
Doyle Mittie Chief Medical Officer | Exempt | Jun 30, 2026 | $36,368.75 | 2,875 | $12.65 | 54,651 |
Doyle Mittie Chief Medical Officer | Exempt | Jun 30, 2026 | $14,303.16 | 1,779 | $8.04 | 56,430 |
Doyle Mittie Chief Medical Officer | Sell | Jun 30, 2026 | $93,080.00 | 4,654 | $20.00 | 51,776 |
Philip Ron M | Award | Jun 23, 2026 | $0.00 | 40,200 | $0.00 | 40,200 |
Doyle Mittie Chief Medical Officer | Exempt | Jun 23, 2026 | $0.00 | 1,450 | $0.00 | 116,871 |
Doyle Mittie Chief Medical Officer | Exempt | Jun 23, 2026 | $11,658.00 | 1,450 | $8.04 | 53,226 |
Doyle Mittie Chief Medical Officer | Sell | Jun 23, 2026 | $26,100.00 | 1,450 | $18.00 | 51,776 |
Riley Jennifer Chief Strategy Officer | In Kind | Jun 10, 2026 | $7,702.80 | 588 | $13.10 | 39,696 |
Sullivan Christopher Ryan Chief Financial Officer | In Kind | Jun 10, 2026 | $1,807.80 | 138 | $13.10 | 40,773 |
Doyle Mittie Chief Medical Officer | In Kind | Jun 10, 2026 | $14,200.40 | 1,084 | $13.10 | 51,776 |
VARKI PAUL Chief Legal Officer | In Kind | Jun 10, 2026 | $14,161.10 | 1,081 | $13.10 | 32,576 |
Doyle Mittie Chief Medical Officer | Exempt | Apr 06, 2026 | $0.00 | 3,970 | $0.00 | 210,530 |
Doyle Mittie Chief Medical Officer | Exempt | Apr 06, 2026 | $50,220.50 | 3,970 | $12.65 | 7,592 |
Doyle Mittie Chief Medical Officer | Sell | Apr 06, 2026 | $71,508.43 | 3,970 | $18.01 | 3,622 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Apr 02, 2026 | $105,553.14 | 6,200 | $17.02 | 19,118 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Apr 02, 2026 | $31,269.97 | 1,780 | $17.57 | 17,338 |
Doyle Mittie Chief Medical Officer | Exempt | Apr 01, 2026 | $0.00 | 679 | $0.00 | 148,329 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Apr 01, 2026 | $7,929.00 | 500 | $15.86 | 32,797 |
Doyle Mittie Chief Medical Officer | Exempt | Apr 01, 2026 | $5,459.16 | 679 | $8.04 | 4,301 |
Sullivan Christopher Ryan Chief Financial Officer | Sell | Apr 01, 2026 | $125,840.91 | 7,479 | $16.83 | 25,318 |
Doyle Mittie Chief Medical Officer | Sell | Apr 01, 2026 | $10,864.00 | 679 | $16.00 | 3,622 |
Jain Rita | Award | Mar 31, 2026 | $16,242.07 | 1,339 | $12.13 | 1,339 |
Lind Kevin Robert | Award | Mar 31, 2026 | $16,618.10 | 1,370 | $12.13 | 1,370 |
KAPLAN GILLA | Exempt | Mar 28, 2026 | $0.00 | 3,166 | $0.00 | 3,167 |
Sullivan Christopher Ryan Chief Financial Officer | Exempt | Mar 28, 2026 | $0.00 | 24,200 | $0.00 | 24,200 |